Industry sessions

AbbVie Inc. | 6 December | 13:30–14:30 | Plenary hall

Insights into the preventive treatment of migraine and impact on patient outcomes

Speakers:
Ian Finkelstein
Toronto Headache and Pain Clinic, Canada

Antonio Russo
University of Campagna “Luigi Vanvitelli”, Italy

Promotional meeting organized and funded by AbbVie. AbbVie Products will be discussed in this meeting.
ALL-NEUM-230018| November 2023

Teva Pharmaceuticals Europe B.V. | 6 December |  16:15–17:15 | Plenary hall

Targeting CGRP in migraine prevention: What do we still need to know?

Speakers: Simona Sacco, L’Aquila, IT | Michail Vikelis, Glyfada, GR | Dagny Holle-Lee, Essen, DE

Click here for detailed information

Pfizer Inc. | 7 December |  11:45–12:45 | Plenary hall

How we can harness gepants in clinical practice, today and into the future

Speakers: Jelena Pavlovic, US | Christina Tassorelli, IT |  Messoud Ashina, DK

In this session we will explore the future of migraine management. Speakers will share insights on clinical evidence for the use of gepants to both treat and prevent migraine, including triptan refractory and long-term data. Engage with our expert panel in an interactive session as they discuss bridging clinical trial data to real world practice. The session will conclude with an audience Q&A.

Click here for detailed information

AbbVie Inc. | 7 December |  14:00–15:00 | Breakout room 2

Supporting patients with migraine: Approaches to patient management

Speakers:
Cristina Tassorelli
University of Pavia, Italy

Mona Ghadiri-Sani
The Walton Centre NHS Foundation Trust, UK

Promotional meeting organized and funded by AbbVie. AbbVie Products will be discussed in this meeting.
ALL-NEUM-230014| November 2023

Eli Lilly and Company | Plenary Hall | 11:45–12:45

Journeying Through Key Stages of Migraine Management: Case-Based Learning

Speakers: Margarita Sanchez, Madrid, ES | Giorgio Lambru, London GB | Uwe Reuter, Greifswald, DE

Join Lilly to learn more about:

• Enhancing knowledge on patient-centered care through effective patient assessment
• Facilitating evidence-based decision-making in long term management of patients with migraine

AbbVie Inc. | 14:15–15:15 | Breakout room 1

How are the goals of migraine prevention evolving?

Speakers: Rami Burstein, Boston, US | Manjit Matharu, London, GB | Franchesca Fiorito, San Juan, PR

Click here for detailed information

Lundbeck A/S | 15:45–16:45 | Plenary hall

Understanding migraine, optimising outcomes

Speakers: Patricia Pozo-Rosich, Barcelona, ES | Peter Goadsby, London, GB | Jessica Ailani, Washington, DC, US

Click here for detailed information